Global Recombinant Protein Biopharmaceuticals Market Projected to Reach USD 296.91 Billion by 2034, Growing at a CAGR of 9.2%; Key Players and Trends According to a new report from Intel Market Research, Global Recombinant Protein Biopharmaceuticals market was valued at USD 162.42 billion in 2024 and is projected to reach USD 296.91 billion by 2034, growing at a robust CAGR of 9.2% during the forecast period (2024-2034). This growth is fueled by increasing prevalence of chronic diseases, advancements in biotechnology, and rising demand for targeted therapies that offer superior efficacy with fewer side effects. 📥 Download FREE Sample Report: https://www.intelmarketresearch.com/download-free-sample/30563/recombinant-protein-biopharmaceuticals-market